2-219055843-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002181.4(IHH):​c.600G>A​(p.Thr200Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.099 in 1,609,750 control chromosomes in the GnomAD database, including 8,064 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 803 hom., cov: 32)
Exomes 𝑓: 0.099 ( 7261 hom. )

Consequence

IHH
NM_002181.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -4.65

Publications

13 publications found
Variant links:
Genes affected
IHH (HGNC:5956): (Indian hedgehog signaling molecule) This gene encodes a member of the hedgehog family of proteins. The encoded preproprotein is proteolytically processed to generate multiple protein products, including an N-terminal fragment that is involved in signaling. Hedgehog family proteins are essential secreted signaling molecules that regulate a variety of developmental processes including growth, patterning and morphogenesis. The protein encoded by this gene specifically plays a role in bone growth and differentiation. Mutations in this gene are the cause of brachydactyly type A1, which is characterized by shortening or malformation of the fingers and toes. Mutations in this gene are also the cause of acrocapitofemoral dysplasia. [provided by RefSeq, Nov 2015]
IHH Gene-Disease associations (from GenCC):
  • brachydactyly type A1
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • acrocapitofemoral dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 2-219055843-C-T is Benign according to our data. Variant chr2-219055843-C-T is described in ClinVar as Benign. ClinVar VariationId is 334443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.65 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.138 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IHHNM_002181.4 linkc.600G>A p.Thr200Thr synonymous_variant Exon 3 of 3 ENST00000295731.7 NP_002172.2 Q14623

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IHHENST00000295731.7 linkc.600G>A p.Thr200Thr synonymous_variant Exon 3 of 3 1 NM_002181.4 ENSP00000295731.5 Q14623

Frequencies

GnomAD3 genomes
AF:
0.103
AC:
15594
AN:
152134
Hom.:
799
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.113
Gnomad AMI
AF:
0.124
Gnomad AMR
AF:
0.0950
Gnomad ASJ
AF:
0.103
Gnomad EAS
AF:
0.147
Gnomad SAS
AF:
0.0962
Gnomad FIN
AF:
0.0830
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0976
Gnomad OTH
AF:
0.114
GnomAD2 exomes
AF:
0.100
AC:
24420
AN:
243016
AF XY:
0.0987
show subpopulations
Gnomad AFR exome
AF:
0.117
Gnomad AMR exome
AF:
0.104
Gnomad ASJ exome
AF:
0.0964
Gnomad EAS exome
AF:
0.147
Gnomad FIN exome
AF:
0.0854
Gnomad NFE exome
AF:
0.0954
Gnomad OTH exome
AF:
0.0991
GnomAD4 exome
AF:
0.0986
AC:
143680
AN:
1457498
Hom.:
7261
Cov.:
36
AF XY:
0.0984
AC XY:
71369
AN XY:
725192
show subpopulations
African (AFR)
AF:
0.119
AC:
3976
AN:
33472
American (AMR)
AF:
0.102
AC:
4571
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.0962
AC:
2512
AN:
26110
East Asian (EAS)
AF:
0.163
AC:
6471
AN:
39682
South Asian (SAS)
AF:
0.0936
AC:
8069
AN:
86244
European-Finnish (FIN)
AF:
0.0884
AC:
4370
AN:
49430
Middle Eastern (MID)
AF:
0.0950
AC:
548
AN:
5766
European-Non Finnish (NFE)
AF:
0.0962
AC:
106994
AN:
1111792
Other (OTH)
AF:
0.102
AC:
6169
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
8203
16406
24610
32813
41016
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3996
7992
11988
15984
19980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.103
AC:
15619
AN:
152252
Hom.:
803
Cov.:
32
AF XY:
0.101
AC XY:
7548
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.113
AC:
4688
AN:
41542
American (AMR)
AF:
0.0950
AC:
1454
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
359
AN:
3470
East Asian (EAS)
AF:
0.146
AC:
757
AN:
5172
South Asian (SAS)
AF:
0.0961
AC:
463
AN:
4818
European-Finnish (FIN)
AF:
0.0830
AC:
882
AN:
10622
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0976
AC:
6639
AN:
68010
Other (OTH)
AF:
0.116
AC:
244
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
750
1501
2251
3002
3752
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0954
Hom.:
967
Bravo
AF:
0.106
Asia WGS
AF:
0.148
AC:
512
AN:
3478
EpiCase
AF:
0.0976
EpiControl
AF:
0.0954

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 14651602) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Acrocapitofemoral dysplasia Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Brachydactyly type A1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
0.16
DANN
Benign
0.85
PhyloP100
-4.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3731878; hg19: chr2-219920565; COSMIC: COSV55393795; COSMIC: COSV55393795; API